AstraZeneca and MSD’s Lynparza (olaparib) has been approved in the European Union (EU) for the 1st-line maintenance treatment with bevacizumab...
Read more
TFF Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, and Augmenta Bioworks, Inc., a biotechnology company enabling breakthroughs in medicine through immune...
Read more
Stirling Ultracold, innovative developer and manufacturer of ultra-low temperature (ULT) freezers for life science and biopharma research, announced it is...
Read more
Roche announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult...
Read more
The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), União Química Farmacêutica Nacional and the Government of the State...
Read more
Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the expansion of its Maryland...
Read more
Eli Lilly and Company and Incyte announced positive data for Olumiant will be presented at ACR Convergence 2020, the American...
Read more
Novartis announced that the European Commission (EC) has approved Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or...
Read more
Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture...
Read more
East Lyme, Connecticut, USA: Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
